Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2012
Total Assets: $2.08B
Liabilities Breakdown FY2012
Total Liabilities: $835.1M
Asset Breakdown
Total Assets: $2.08B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $230.3M | 11.1% |
| Accounts Receivable | $593.2M | 28.5% |
| Inventory | $28.6M | 1.4% |
| Property, Plant & Equipment | $379.9M | 18.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $848.4M | 40.8% |
Liabilities Breakdown
Total Liabilities: $835.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $38.9M | 4.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $796.2M | 95.3% |